FEMASYS INC FEMY
COM NEW · Common Stock · CUSIP 31447E204
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersSuwanee, GA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 8.4m as of 2026-08-13, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $4.18.
Biggest buyers
| VANGUARD CAPITAL MANAGEMENT LLC | New | +62.2k |
| JANE STREET GROUP, LLC | New | +52.5k |
| GEODE CAPITAL MANAGEMENT, LLC | New | +30.9k |
| UBS Group AG | New | +18.8k |
| CITADEL ADVISORS LLC | New | +16.9k |
| VANGUARD FIDUCIARY TRUST CO | New | +12.5k |
| OSAIC HOLDINGS, INC. | New | +2.4k |
| BlackRock, Inc. | New | +1.8k |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | New | +1.0k |
| Arax Advisory Partners | New | +900 |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Nantahala Capital Partners Limited Partnership
13D · may seek influence
new · filed 2026-08-17
Stated purposeThe disclosure regarding the SPA and the Purchase set forth above in Item 3 is incorporated herein by reference. The Issuer has further described the SPA, the Purchase and the Side Letter in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the "SEC") on August 14, 2026. Pursuant to a side letter (the "Side Letter") entered into by Nantahala and the Issuer on August 7, 2026, for so long as Nantahala beneficially owns at least 15% of the outstanding shares of Common Stock (which determination shall be made without regard to the Beneficial Ownership Limitation), until the tenth anniversary of the Purchase, the board of directors (the "Board") of the Issuer shall appoint a Nantahala designee as a member of the Board (and any of its committees), subject to t… Full filing |
10.0% |
| Rosalind Advisors, Inc. 13G · exempt (held before listing) new · filed 2026-08-14 | 9.9% |
| Stonepine Capital Management, LLC 13G · passive investor new · filed 2026-08-31 | 7.2% |
| Empery Asset Management, LP 13G · institution new · filed 2026-10-15 | 5.6% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 0 | — | 0 | — | — |
| Q1 2026 | 0 | — | 0 | — | — |
| Q2 2026 | 0 | — | 0 | — | — |
| Q3 2026 | 5 | $74.0k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2026-08-07 | Lee-Sepsick Kathy Chief Executive Officer, director | Bought | $50.0k15.6k shares |
| 2026-08-07 | Elefant Dov Chief Financial Officer | Bought | $50.0k15.6k shares |
| 2026-08-07 | Canning John Charles Chief Operating Officer | Bought | $14.0k4.4k shares |
| 2026-08-07 | Sipos Jeremy Alexander Chief Technology Officer | Bought | $10.0k3.1k shares |
| 2026-08-07 | Mifek Jeffrey Gerald Chief Clinical-Medical Affairs | Bought | $10.0k3.1k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Dauntless Investment Group, LLC 13.54% of their portfolio | 1.9m $7.8m | Not comparable |
| VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 62.2k $260.1k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 52.5k $219.5k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 30.9k $129.3k | New |
| UBS Group AG 0.00% of their portfolio | 18.8k $78.5k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 16.9k $70.7k | New |
| VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio | 12.5k $52.2k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 2.4k $10.0k | New |
| BlackRock, Inc. 0.00% of their portfolio | 1.8k $7.5k | New |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio | 1.0k $4.2k | New |
| Arax Advisory Partners 0.00% of their portfolio | 900 $3.8k | New |
| WHITTIER TRUST CO OF NEVADA INC 0.00% of their portfolio | 794 $3.1k | New |
| TRUST CO OF TOLEDO NA /OH/ 0.00% of their portfolio | 87 $364 | New |
| IFP Advisors, Inc 0.00% of their portfolio | 50 $209 | New |
| BARCLAYS PLC 0.00% of their portfolio | 8 $33 | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 7 $29 | New |
| MORGAN STANLEY 0.00% of their portfolio | 3 $13 | New |